Characterization of a novel porcine endothelin(B) receptor splice variant

Citation
P. Nambi et al., Characterization of a novel porcine endothelin(B) receptor splice variant, J PHARM EXP, 292(1), 2000, pp. 247-253
Citations number
45
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
ISSN journal
00223565 → ACNP
Volume
292
Issue
1
Year of publication
2000
Pages
247 - 253
Database
ISI
SICI code
0022-3565(200001)292:1<247:COANPE>2.0.ZU;2-Q
Abstract
Screening of porcine cerebellum cDNA library with porcine endothelin(B) (ET B) receptor cDNA revealed a novel ETB receptor cDNA that is distinctly diff erent from the wild-type ETB receptor in length and the amino acid sequence at the C-terminal end. This sequence appears to represent alternate splici ng of the carboxy terminal end of ETB receptor, resulting in a polypeptide of 429 amino acids in length, which is 14 amino acids shorter than the wild -type porcine ETB receptor. Characterization of the wild-type and alternate ly spliced ETB receptors expressed in COS cells revealed that both receptor s displayed very similar binding [apparent dissociation constant (K-d) and maximum binding (B-max) for I-125-ET-1 were 71 pM and 1.6 pmol/mg protein f or wild-type and 81 pM and 1.2 pmol/mg protein for splice variant ETB recep tors] as well as functional properties. These data suggest that the differe nces in the amino acids at the C-terminal end had no effect on binding or f unctional coupling of these alternately spliced ETB receptors.